Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib taken by mouth helps treat hair loss in children.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.